Selective manipulation of specific receptors...
Posted: Fri Oct 14, 2016 5:49 am
Mouse experiments with compounds having opposite actions on two receptors for tumour necrosis factor (TNF) — a key factor in neurodegeneration — explains why earlier trials of TNF blockers in multiple sclerosis (MS) went wrong, and paves the way for more selective drugs targeting the system to stop MS neurodegeneration...Read more - http://www.ms-uk.org/selective-manipula ... ies-141016